131st MAINE LEGISLATURE
		LD 2282		LR 3161(02)
	An Act to Provide Greater Transparency About the Cost of Insulin and to Promote the Availability of Low-cost Insulin in the State
	Fiscal Note for Bill as Engrossed with: No Amendments
	Committee: Health Coverage, Insurance and Financial Services
Fiscal Note
Current biennium revenue decrease - Other Special Revenue Funds Minor cost increase - General Fund
Fiscal Detail and Notes
	This bill exempts a manufacturer of insulin that is a nonprofit organization from paying the $75,000 registration fee. It is unclear whether any such organizations currently manufacture insulin, but manufacturers of 500,000 units or less are already exempt from the fee. Any decrease in dedicated revenue to the Maine Board of Pharmacy within the Department of Professional and Financial Regulation cannot be determined at this time.
	Any additional costs to the Maine Health Data Organization from the provisions of this bill are expected to be minor and can be absorbed within existing budgeted resources.